Show simple item record

dc.contributor.authorFarrell, Helena
dc.date.accessioned2013-12-23T14:44:57Z
dc.date.available2013-12-23T14:44:57Z
dc.date.issued2013-11
dc.identifier.urihttp://hdl.handle.net/10147/308928
dc.descriptionType 2 diabetes is a progressive condition, where beta cell function declines and fails, therefore requiring almost all individuals to be commenced on insulin therapy. There appears to be a very real clinical inertia within community care in relation to the initiation of insulin and GLP-1 hormones in the community. This appears to be dependent on a number of variables, most notably cost, efficacy and side-effects. Also access to specialist supports such as access to a diabetes specialist nurse and consultant care has to be considered. This is not just unique to Ireland, it is a worldwide phenomenon. As with most insulin initiation and GLP-1 hormone initiation in the community, it is primarily for individuals with type 2 diabetes, so this article will focus on that population.en_GB
dc.language.isoenen
dc.publisherNursing in General Practiceen_GB
dc.subjectDIABETES MELLITUSen_GB
dc.subjectCOMMUNITY HEALTHen_GB
dc.titleInsulin initiation in the communityen_GB
dc.typeArticleen
dc.identifier.journalNursing in general practiceen_GB
refterms.dateFOA2018-08-23T10:37:59Z


Files in this item

Thumbnail
Name:
NOV13Art4.pdf
Size:
82.27Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record